: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Actelis Networks(ASNS)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-23-075577 Act: 34 Size: 4 MB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, item 3.01 Accession Number: 0001213900-23-072847 Act: 34 Size: 196 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-23-070935 Act: 34 Size: 357 KB 网页链接
$Actelis Networks(ASNS)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-23-070438 Act: 34 Size: 4 MB 网页链接
$Actelis Networks(ASNS)$ NT 10-Q/A [Amend] Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001213900-23-069409 Act: 34 Size: 40 KB 网页链接
$Actelis Networks(ASNS)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001213900-23-066348 Act: 34 Size: 27 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, item 5.07 Accession Number: 0001213900-23-064125 Act: 34 Size: 207 KB 网页链接
$Actelis Networks(ASNS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001213900-23-057422 Size: 2 KB 网页链接
$Actelis Networks(ASNS)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001213900-23-056498 Act: 34 Size: 255 KB 网页链接
$Actelis Networks(ASNS)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-23-054860 Act: 34 Size: 163 KB 网页链接